P674: UPDATED RESULTS OF A PHASE 1B STUDY OF IBRUTINIB (IBR) PLUS OBINUTUZUMAB (OBIN) IN PATIENTS WITH RELAPSED OR REFRACTORY (R/R) CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
Huvudupphovsmän: | , , , , , , , , , , , , , , , |
---|---|
Materialtyp: | Artikel |
Språk: | English |
Publicerad: |
Wiley
2022-06-01
|
Serie: | HemaSphere |
Länkar: | http://journals.lww.com/10.1097/01.HS9.0000845580.45096.48 |